Yuanbao ADR saw its IBD SmartSelect Composite Rating jump to 96 Monday, up from 94 the day before.
Lean How — And When — To Sell Stocks
The upgrade means the stock is now outpacing 96% of all other stocks in terms of key performance metrics and technical strength. Winning stocks often have a 95 or higher score in the early stages of a new price run, so that's a good starting point when looking for the best stocks to buy and watch.
Yuanbao ADR is not currently near a proper entry. See if the stock goes on to form a new base and offer a new buying opportunity. Keep in mind that it's a thinly traded stock, with average daily dollar volume under $8 million.
The stock sports an 81 EPS Rating, meaning its recent quarterly and longer-term annual earnings growth is outpacing 81% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
The company posted a 102% rise in earnings for Q1. Top line growth came in at 43%, down from 59% in the previous quarter. The company's next quarterly report is expected on or around Jan. 1.
Yuanbao ADR holds the No. 2 rank among its peers in the Insurance-Diversified industry group. Palomar Holdings is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
